Dr. Tanushree Agrawal, MD

Dr. Agrawal practices at Saint Francis Hospital in Tulsa, Oklahoma, part of Saint Francis Health System.

Dr. Agrawal's NPI, 1295187383, was assigned on July 13, 2016. Dr. Agrawal holds Oklahoma license 39413.

Dr. Agrawal's primary practice is Saint Francis Hospital, at 6161 South Yale, Tulsa, OK 74136 in Tulsa County. The practice phone is (918) 494-8467.

Dr. Agrawal's primary practice is Saint Francis Hospital in Tulsa, Oklahoma, part of Saint Francis Health System. Dr. Agrawal is also affiliated with Saint Francis Hospital South. The medical group on file is Warren Clinic. Dmand AI also links Dr. Agrawal to 3 more hospitals, 4 medical groups and 3 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Agrawal practices, 8 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Agrawal's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Agrawal's licenses on file in 2 states: Oklahoma and Texas.

CMS data shows 3,208 Medicare services from Dr. Agrawal across 15 procedure codes in 2024, for 2,104 Medicare patients. Medicare paid $80,536 for them.

CMS counts 2,104 Medicare patients who saw Dr. Agrawal in 2024. The largest group is 75 to 84, with 809 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 2.19, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Agrawal's median patient age at 70, with 55% women.

In 2024, Dr. Agrawal wrote 1,898 Medicare Part D claims for 344 patients. 81% of them were for generic drugs. CMS names the drug for 1,763 of them, across 26 drugs with 11 or more claims each, at $346,500 in total drug cost. In 2023, CMS named 1,010 claims across 22 drugs.

Dr. Agrawal accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 17 papers to Dr. Agrawal, published from 2019 to 2023. 2019 was the busiest year, with 4. Dr. Agrawal has published most often in Cureus. Dr. Agrawal's most frequent co-authors are Mahwash Kassi, MD, Arvind Bhimaraj, MD and Ashrith Guha, MD.

CMS Open Payments shows 67 general payments to Dr. Agrawal from 12 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Abbott Laboratories paid the most, $1,165.